National Bank of Canada’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,250
Closed -$35M 3192
2024
Q4
$35M Hold
7,250
0.04% 402
2024
Q3
$32.9M Hold
7,250
0.04% 379
2024
Q2
$29.9M Sell
7,250
-2,500
-26% -$359K 0.04% 300
2024
Q1
$40.8M Buy
9,750
+6,250
+179% +$897K 0.06% 261
2023
Q4
$13.2M Buy
+3,500
New +$455K 0.02% 503
2023
Q1
Sell
-400
Closed -$3.5M 2883
2022
Q4
$3.5M Sell
400
-5,400
-93% -$716K 0.01% 722
2022
Q3
$19.3M Buy
5,800
+5,400
+1,350% +$696K 0.1% 215
2022
Q2
$2.86M Buy
+400
New +$52.4K 0.01% 714

Other funds holding XLV

National Bank of Canada's XLV Position: Q2 2026 in Review

National Bank of Canada increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 68% in Q2 2026, buying an estimated $9.76M and bringing the position to 161,620 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #482.

National Bank of Canada first reported a position in XLV in Q4 2021 and has held it in 19 quarters since. The position peaked at $30.2M in Q3 2025. 1,322 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • National Bank of Canada held 161,620 shares of State Street Health Care Select Sector SPDR ETF worth $25.6M as of Q2 2026.
  • National Bank of Canada bought 65,605 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $9.76M.
  • State Street Health Care Select Sector SPDR ETF made up 0.02% of National Bank of Canada's portfolio in Q2 2026, its #482 holding.
  • National Bank of Canada first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's State Street Health Care Select Sector SPDR ETF position peaked at $30.2M in Q3 2025.
  • 1,322 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.